MIR8070

Across TCGA pan-cancer cohorts, MIR8070 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR8070 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher MIR8070 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR8070 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

LIHC, STAD, and COAD are the cancer types where MIR8070 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.191	0.679	<.001	60	view →
STAD	DFS	Tertile	IV	0.182	0.523	.007	36	view →
COAD	DFS	Tertile	II,III,IV	0.500	0.682	.010	30	view →
BLCA	OS	Tertile	All	0.850	0.542	.030	18	view →
UVM	DFS	Tertile	III,IV	0.079	0.674	.020	18	view →
PAAD	OS	Tertile	All	0.245	0.594	.005	9	view →
KIRC	OS	Tertile	All	0.729	0.888	.035	6	view →
THCA	OS	Tertile	II,III,IV	0.895	0.967	.030	6	view →
ESCA	OS	Tertile	All	0.577	0.717	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR8070–LIHC (OS)

Open the LIHC breakdown →